A kidney cancer drug from Aveo Pharmaceuticals (AVEO) outperformed an approved drug from Onyx...

|About: AVEO Pharmaceuticals, Inc. (AVEO)|By:, SA News Editor

A kidney cancer drug from Aveo Pharmaceuticals (AVEO) outperformed an approved drug from Onyx Pharmaceuticals (ONXX) in a late-stage study comparing the two treatments head-to-head. Based on these data, the firm says it plans to submit for marketing approval of tivozanib in the United States and Europe this year.